News from the healthcare data industry
Oct 5, 2022 For patients with mCSPC, the current standard of treatment is to intensify androgen deprivation therapy (ADT) with docetaxel or androgen receptor axis-targeted therapy (ARAT: abiraterone, apalutamide, enzalutamide)....
Background – Colorectal liver oligometastases (CLO) represents a subset of metastatic colorectal cancer (mCRC) patients who may be eligible to undergo curative intent resection which can improve survival. However, given the...
Relationship advances health system’s clinical trial and precision medicine options and national research consortium’s real world data while increasing geographic and patient diversity SPARTANBURG, S.C., Sept. 30, 2022 /PRNewswire/ — Guardian Research Network® (GRN) announced...
The first Fully Digital, Clinical Trial Solution for Oncology, Hematology & Urology CAMBRIDGE, Mass., Sept. 29, 2022 /PRNewswire/ — ConcertAI, LLC (ConcertAI) announced the launch of its new Digital Trial Software-as-a-Service solution. Powered...
CHICAGO and LOUGHBOROUGH, Sept. 27, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc.(NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising noninvasive wearable diagnostic devices and supporting...
BELLEVUE, Wash., Sept. 27, 2022 (GLOBE NEWSWIRE) — Today, Truveta announced a strategic collaborative agreement with Boston Scientific to improve long-term patient care and gain insights into healthcare disparities. Through...
Collaboration Utilizes RWD-enabled Capabilities Across Hospitals and Research Organizations to Transform the Elimination of Disparities NEW ORLEANS and CAMBRIDGE, Mass., Sept. 27, 2022 /PRNewswire/ — The National Cancer Institute Community Oncology Research Program (NCI...
CHICAGO and WARSAW, Poland, Sept. 26, 2022 /PRNewswire/ — Prosoma Digital Therapeutics, innovators in reinventing healthcare for oncology patients, has partnered with EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, to...
Underdosing of non-vitamin K oral anticoagulants (NOACs) is common in patients with atrial fibrillation (AF), and may be associated with an increased risk of stroke without reducing the risk of...
nference’s new privacy-preserving nSights platform accelerates development of therapeutics and diagnostics for life sciences companies September 21, 2022 08:45 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference, a science-first software company transforming...